tickertape
← runs

JNJ

JOHNSON & JOHNSONeval run
10-K for period ending 2025-12-28gpt-6-luna@none · prompt v4$0.00073.5s9/9 correct vs SECfiling on sec.gov ↗

figures

fieldvaluestatement rowprintedSEC
Total revenue$94.2BR1 Sales to customers94,193 millions$94.2B ✓
Operating income-not printed on this statement--
Net income attributable to the company$26.8BR15 Net earnings26,804 millions$26.8B ✓
Diluted EPS$11.03R22 Total net earnings per share - diluted11.03$11.03 ✓
Cash and cash equivalents$19.7BR3 Cash and cash equivalents (Notes 1 and 2)19,709 millions$19.7B ✓
Total assets$199.2BR14 Total assets199,210 millions$199.2B ✓
Total liabilities$117.7BR29 Total liabilities117,666 millions$117.7B ✓
Total shareholders' equity attributable to the company$81.5BR37 Total shareholders’ equity81,544 millions-
Net cash from operating activities$24.5BR18 Net cash flows from operating activities24,530 millions$24.5B ✓
Net cash from investing activities-$23.6BR28 Net cash (used by)/from investing activities(23,588) millions-$23.6B ✓
Net cash from financing activities-$5.5BR45 Net cash used by financing activities(5,539) millions-$5.5B ✓

checks

  • assets = liabilities + equity · total assets equals total liabilities and equity
  • equity excludes minority interests · not applicable: no noncontrolling interest line printed
  • net income is before preferred dividends · net income is not the after-preferred-dividends line
  • diluted EPS is for total net income · diluted EPS is for total net income
  • net income excludes minority interests · not applicable: no noncontrolling interest line printed
  • cash flows tie to the change in cash · operating + investing + financing (+ FX) equals the net change in cash

trace

  1. 0locator (code)0.17s
    {
  "tables": 235,
  "exhibits": [],
  "documents": 1
}
    {
  "income": {
    "rows": 26,
    "scale": 1000000,
    "score": 51,
    "heading": " and subsidiaries consolidated statements of earnings (Dollars and Shares in Millions Except Per Share Amounts) (Note 1)",
    "tableIndex": 72,
    "runnerUpScore": 28.25
  },
  "balance": {
    "rows": 39,
    "scale": 1000000,
    "score": 53,
    "heading": "ance sheets At December 28, 2025 and December 29, 2024 (Dollars in Millions Except Share and Per Share Amounts) (Note 1)",
    "tableIndex": 70,
    "runnerUpScore": 10
  },
  "cashflow": {
    "rows": 61,
    "scale": 1000000,
    "score": 53.25,
    "heading": "46 Johnson & Johnson and subsidiaries consolidated statements of cash flows (Dollars in Millions) (Note 1)",
    "tableIndex": 78,
    "runnerUpScore": 10
  }
}
  2. 1cash flow agent1.90s · 2082 tokens · $0.0003
    {
  "rows": 61,
  "retryHint": null,
  "tableIndex": 78
}
    {
  "figures": [
    {
      "note": "This is the operating-activities section total, including changes in assets and liabilities.",
      "field": "operatingCashFlow",
      "scale": 1000000,
      "value": 24530000000,
      "printed": "24,530",
      "rowIndex": 18,
      "rowLabel": "Net cash flows from operating activities",
      "priorValue": 24266000000,
      "agentPrinted": "24,530",
      "failedChecks": [],
      "priorPrinted": "24,266",
      "groundingMismatch": false
    },
    {
      "note": "This is the investing-activities section total.",
      "field": "investingCashFlow",
      "scale": 1000000,
      "value": -23588000000,
      "printed": "(23,588)",
      "rowIndex": 28,
      "rowLabel": "Net cash (used by)/from investing activities",
      "priorValue": -18599000000,
      "agentPrinted": "(23,588)",
      "failedChecks": [],
      "priorPrinted": "(18,599)",
      "groundingMismatch": false
    },
    {
      "note": "This is the financing-activities section total.",
      "field": "financingCashFlow",
      "scale": 1000000,
      "value": -5539000000,
      "printed": "(5,539)",
      "rowIndex": 45,
      "rowLabel": "Net cash used by financing activities",
      "priorValue": -3132000000,
      "agentPrinted": "(5,539)",
      "failedChecks": [],
      "priorPrinted": "(3,132)",
      "groundingMismatch": false
    }
  ],
  "statement": "cashflow",
  "tableIndex": 78,
  "priorColumn": 1,
  "currentColumn": 0
}
  3. 2balance sheet agent2.19s · 1562 tokens · $0.0002
    {
  "rows": 39,
  "retryHint": null,
  "tableIndex": 70
}
    {
  "figures": [
    {
      "note": "This is the balance sheet’s cash and cash equivalents line.",
      "field": "cash",
      "scale": 1000000,
      "value": 19709000000,
      "printed": "19,709",
      "rowIndex": 3,
      "rowLabel": "Cash and cash equivalents (Notes 1 and 2)",
      "priorValue": 24105000000,
      "agentPrinted": "19,709",
      "failedChecks": [],
      "priorPrinted": "24,105",
      "groundingMismatch": false
    },
    {
      "note": "This row prints total assets.",
      "field": "totalAssets",
      "scale": 1000000,
      "value": 199210000000,
      "printed": "199,210",
      "rowIndex": 14,
      "rowLabel": "Total assets",
      "priorValue": 180104000000,
      "agentPrinted": "199,210",
      "failedChecks": [],
      "priorPrinted": "180,104",
      "groundingMismatch": false
    },
    {
      "note": "This is the standalone total liabilities row, not liabilities and shareholders’ equity.",
      "field": "totalLiabilities",
      "scale": 1000000,
      "value": 117666000000,
      "printed": "117,666",
      "rowIndex": 29,
      "rowLabel": "Total liabilities",
      "priorValue": 108614000000,
      "agentPrinted": "117,666",
      "failedChecks": [],
      "priorPrinted": "108,614",
      "groundingMismatch": false
    },
    {
      "note": "This row prints total shareholders’ equity, excluding any noncontrolling interest.",
      "field": "totalEquity",
      "scale": 1000000,
      "value": 81544000000,
      "printed": "81,544",
      "rowIndex": 37,
      "rowLabel": "Total shareholders’ equity",
      "priorValue": 71490000000,
      "agentPrinted": "81,544",
      "failedChecks": [],
      "priorPrinted": "71,490",
      "groundingMismatch": false
    }
  ],
  "statement": "balance",
  "tableIndex": 70,
  "priorColumn": 1,
  "currentColumn": 0
}
  4. 3income statement agent3.03s · 1582 tokens · $0.0002
    {
  "rows": 26,
  "retryHint": null,
  "tableIndex": 72
}
    {
  "figures": [
    {
      "note": "Sales to customers is the company-wide revenue line; no separate total revenue line is printed.",
      "field": "revenue",
      "scale": 1000000,
      "value": 94193000000,
      "printed": "94,193",
      "rowIndex": 1,
      "rowLabel": "Sales to customers",
      "priorValue": 88821000000,
      "agentPrinted": "94,193",
      "failedChecks": [],
      "priorPrinted": "88,821",
      "groundingMismatch": false
    },
    {
      "note": "The statement does not print operating income or an equivalent operating-profit line.",
      "field": "operatingIncome",
      "scale": 1000000,
      "value": null,
      "printed": null,
      "rowIndex": null,
      "rowLabel": null,
      "priorValue": null,
      "agentPrinted": null,
      "failedChecks": [],
      "priorPrinted": null,
      "groundingMismatch": false
    },
    {
      "note": "Net earnings is the only net-income line printed and no noncontrolling-interest attribution is shown.",
      "field": "netIncome",
      "scale": 1000000,
      "value": 26804000000,
      "printed": "26,804",
      "rowIndex": 15,
      "rowLabel": "Net earnings",
      "priorValue": 14066000000,
      "agentPrinted": "26,804",
      "failedChecks": [],
      "priorPrinted": "14,066",
      "groundingMismatch": false
    },
    {
      "note": "Total net earnings per share—diluted is the total diluted EPS line.",
      "field": "epsDiluted",
      "scale": 1,
      "value": 11.03,
      "printed": "11.03",
      "rowIndex": 22,
      "rowLabel": "Total net earnings per share - diluted",
      "priorValue": 5.79,
      "agentPrinted": "11.03",
      "failedChecks": [],
      "priorPrinted": "5.79",
      "groundingMismatch": false
    }
  ],
  "statement": "income",
  "tableIndex": 72,
  "priorColumn": 1,
  "currentColumn": 0
}
  5. 4reconciler (code)0.00s
    null
    [
  {
    "name": "balance_identity",
    "detail": "total assets equals total liabilities and equity",
    "fields": [
      "totalAssets"
    ],
    "passed": true,
    "skipped": false,
    "statement": "balance"
  },
  {
    "name": "totalEquity_attribution",
    "detail": "no noncontrolling interest line printed",
    "fields": [
      "totalEquity"
    ],
    "passed": true,
    "skipped": true,
    "statement": "balance"
  },
  {
    "name": "netIncome_before_preferred",
    "detail": "net income is not the after-preferred-dividends line",
    "fields": [
      "netIncome"
    ],
    "passed": true,
    "skipped": false,
    "statement": "income"
  },
  {
    "name": "epsDiluted_total",
    "detail": "diluted EPS is for total net income",
    "fields": [
      "epsDiluted"
    ],
    "passed": true,
    "skipped": false,
    "statement": "income"
  },
  {
    "name": "netIncome_attribution",
    "detail": "no noncontrolling interest line printed",
    "fields": [
      "netIncome"
    ],
    "passed": true,
    "skipped": true,
    "statement": "income"
  },
  {
    "name": "cash_flow_tie",
    "detail": "operating + investing + financing (+ FX) equals the net change in cash",
    "fields": [
      "operatingCashFlow",
      "investingCashFlow",
      "financingCashFlow"
    ],
    "passed": true,
    "skipped": false,
    "statement": "cashflow"
  }
]

Income statement

table #72 · current period is figure column 1
0202520242023
1Sales to customers← Total revenue94,19388,82185,159
2Cost of products sold30,25627,47126,553
3Gross profit63,93761,35058,606
4Selling, marketing and administrative expenses23,67622,86921,512
5Research and development expense14,66517,23215,085
6In-process research and development impairments81211313
7Interest income(1,056)(1,332)(1,261)
8Interest expense, net of portion capitalized (Note 4)971755772
9Other (income) expense, net(7,209)4,6946,634
10Restructuring (Note 20)228234489
11Earnings before provision for taxes on income32,58116,68715,062
12Provision for taxes on income (Note 8)5,7772,6211,736
13Net earnings from continuing operations26,80414,06613,326
14Net earnings from discontinued operations, net of tax (Note 21)--21,827
15Net earnings← Net income attributable to the company26,80414,06635,153
16Net earnings per share (Notes 1 and 15)
17Continuing operations - basic11.135.845.26
18Discontinued operations - basic--8.62
19Total net earnings per share - basic11.135.8413.88
20Continuing operations - diluted11.035.795.20
21Discontinued operations - diluted--8.52
22Total net earnings per share - diluted← Diluted EPS11.035.7913.72
23Average shares outstanding (Notes 1 and 15)
24Basic2,407.42,407.32,533.5
25Diluted2,429.42,429.42,560.4

Balance sheet

table #70 · current period is figure column 1
020252024
1Assets
2Current assets
3Cash and cash equivalents (Notes 1 and 2)← Cash and cash equivalents19,70924,105
4Marketable securities (Notes 1 and 2)393417
5Accounts receivable trade, less allowances $183 (2024, $167)17,17814,842
6Inventories (Notes 1 and 3)14,19112,444
7Prepaid expenses and other receivables4,1534,085
8Total current assets55,62455,893
9Property, plant and equipment, net (Notes 1 and 4)23,16920,518
10Intangible assets, net (Notes 1 and 5)50,40337,618
11Goodwill (Notes 1 and 5)48,77244,200
12Deferred taxes on income (Note 8)6,87410,461
13Other assets14,36811,414
14Total assets← Total assets199,210180,104
15Liabilities and Shareholders’ Equity
16Current liabilities
17Loans and notes payable (Note 7)8,4955,983
18Accounts payable11,99110,311
19Accrued liabilities8,5948,549
20Accrued rebates, returns and promotions19,12417,580
21Accrued compensation and employee related obligations4,5344,126
22Accrued taxes on income (Note 8)1,3883,772
23Total current liabilities54,12650,321
24Long-term debt (Note 7)39,43830,651
25Deferred taxes on income (Note 8)6,7912,448
26Employee related obligations (Notes 9 and 10)6,9577,255
27Long-term taxes payable (Note 1)486390
28Other liabilities9,86817,549
29Total liabilities← Total liabilities117,666108,614
30Commitments and Contingencies (Note 19)
31Shareholders’ equity
32Preferred stock - without par value (authorized and unissued 2,000,000 shares)--
33Common stock - par value $1.00 per share (Note 12) (authorized 4,320,000,000 shares; issued 3,119,843,000 shares)3,1203,120
34Accumulated other comprehensive income (loss) (Note 13)(14,930)(11,741)
35Retained earnings and Additional-paid-in-capital168,978155,791
36Less: common stock held in treasury, at cost (Note 12) (711,904,000 shares and 712,921,000 shares)75,62475,680
37Total shareholders’ equity← Total shareholders' equity attributable to the company81,54471,490
38Total liabilities and shareholders’ equity199,210180,104

Cash flow statement

table #78 · current period is figure column 1
0202520242023
1Cash flows from operating activities
2Net earnings26,80414,06635,153
3Adjustments to reconcile net earnings to cash flows from operating activities:
4Depreciation and amortization of property and intangibles7,5037,3397,486
5Stock based compensation1,3541,1761,162
6Asset write-downs2044051,295
7Charges for acquired in-process research and development1091,841483
8Gain on Kenvue separation--(20,984)
9Net gain on sale of assets/businesses(263)(226)(117)
10Deferred tax provision1,538(2,183)(4,194)
11Credit losses and accounts receivable allowances(1)11-
12Changes in assets and liabilities, net of effects from acquisitions and divestitures:
13Increase in accounts receivable(1,781)(406)(624)
14Increase in inventories(1,450)(1,128)(1,323)
15Increase in accounts payable and accrued liabilities2,3771,6212,346
16(Increase)/Decrease in other current and non-current assets(6,167)1,717(3,480)
17(Decrease)/Increase in other current and non-current liabilities(5,697)335,588
18Net cash flows from operating activities← Net cash from operating activities24,53024,26622,791
19Cash flows (used by) from investing activities
20Additions to property, plant and equipment(4,832)(4,424)(4,543)
21Proceeds from the disposal of assets/businesses, net720675358
22Acquisitions, net of cash acquired (Note 18)(17,541)(15,146)-
23Acquired in-process research and development/related milestones (Note 18)(385)(1,783)(470)
24Purchases of investments(920)(1,726)(10,906)
25Sales of investments1,6612,46219,390
26Credit support agreements activity, net(2,129)1,517(2,963)
27Other (including capitalized licenses and milestones)(162)(174)12
28Net cash (used by)/from investing activities← Net cash from investing activities(23,588)(18,599)878
29Cash flows (used by) from financing activities
30Dividends to shareholders(12,381)(11,823)(11,770)
31Repurchase of common stock(5,953)(2,432)(5,054)
32Proceeds from short-term debt14,58615,27713,743
33Repayment of short-term debt(12,330)(9,463)(22,973)
34Proceeds from long-term debt, net of issuance costs9,1386,660-
35Repayment of long-term debt(1,757)(1,453)(1,551)
36Proceeds from the exercise of stock options/employee withholding tax on stock awards, net3,4188381,094
37Credit support agreements activity, net(226)272(219)
382025 Annual Report47
39202520242023
40Settlement of convertible debt acquired from Shockwave-(970)-
41Proceeds of short and long-term debt, net of issuance cost, related to the debt that transferred to Kenvue at separation--8,047
42Proceeds from Kenvue initial public offering--4,241
43Cash transferred to Kenvue at separation--(1,114)
44Other(34)(38)(269)
45Net cash used by financing activities← Net cash from financing activities(5,539)(3,132)(15,825)
46Effect of exchange rate changes on cash and cash equivalents201(289)(112)
47(Decrease)/Increase in cash and cash equivalents(4,396)2,2467,732
48Cash and cash equivalents from continuing operations, beginning of period24,10521,85912,889
49Cash and cash equivalents from discontinued operations, beginning of period--1,238
50Cash and cash equivalents, beginning of year (Note 1)24,10521,85914,127
51Cash and cash equivalents from continuing operations, end of period19,70924,10521,859
52Cash and cash equivalents from discontinued operations, end of period---
53Cash and cash equivalents, end of year (Note 1)19,70924,10521,859
54Supplemental cash flow data
55Cash paid during the year for:
56Interest1,9771,9901,836
57Interest, net of amount capitalized1,8631,9111,766
58Income taxes, inclusive of discontinued operations6,5396,7148,574
59Supplemental schedule of non-cash investing and financing activities
60Treasury stock issued for employee compensation and stock option plans, net of cash proceeds/ employee withholding tax on stock awards2,5911,5511,435